Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01434706 · ClinicalTrials.gov registry record · NA
Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 22,607
- Enrollment target
NCT01434706 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 22,607 participants.
The verdict
NCT01434706, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 22,607 participants
- Enrollment target
Study Summary
The investigators propose to study the impact of nucleic acid amplification testing (NAT) screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and Less-Sensitive Enzyme linked Immunoassay (LS-EIA) or 'detuned' testing Vironostika, Trinity Biotech BED, or Ortho-Clinical Diagnostic Vistros ECi for early HIV infection in conjunction with routine rapid HIV testing at HIV counseling and testing sites and venues in the San Diego county. The overarching goal of this study is to develop and implement a system to identify, notify and engage into care those individuals with recent HIV infection in order to better define the HIV and Hepatitis C Virus (HCV) epidemics in the San Diego county and to evaluate and characterize HIV transmission dynamics within the San Diego population.
Interventions
- OTHER Nucleic Acid Amplification Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22,607 participants |
| Start Date | 2010-09-16 |
| Est. Completion | 2015-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01434706
The ClinicalTrials.gov registry entry for NCT01434706 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22,607 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nucleic Acid Amplification Testing is the first listed.
NCT01434706 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01434706 about?
NCT01434706 is a clinical study titled "Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection". The investigators propose to study the impact of nucleic acid amplification testing (NAT) screening for acute Human Immunodeficiency Virus (HIV) and Hepatitis C (HCV) infections and Less-Sensitive Enzyme linked Immunoassay (LS-EIA) or 'detuned' testing Vironostika, Trinity Biotech BED, or Ortho-Clin...
What is the current status of trial NCT01434706?
This trial is currently completed. It is a NA study. The enrollment target is 22,607 participants. The study started on 2010-09-16. Estimated completion is 2015-04-07.
What interventions are being tested in trial NCT01434706?
The interventions under investigation include: Nucleic Acid Amplification Testing (OTHER).
Who is sponsoring clinical trial NCT01434706?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.